Client Profile
$8B systematic hedge fund deploying a concentrated biotech strategy.
The challenge: The fund had a high-conviction thesis on a specific biotech company but needed to validate assumptions about FDA approval timelines and market adoption before deploying $200M.
The solution: Over 6 weeks, the fund conducted 47 expert calls with former FDA reviewers, practicing physicians, hospital procurement directors, and competitor executives.
Results
- Thesis validated with quantitative expert sentiment data
- 2 critical risks surfaced and incorporated into position sizing
- $200M position deployed with confidence
